Literature DB >> 18163495

Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.

Jim C Oates1, Stephanie R Shaftman, Sally E Self, Gary S Gilkeson.   

Abstract

OBJECTIVE: Reactive intermediate production is an essential component of the innate immune response that is induced during disease activity in murine lupus. This study was undertaken to determine whether a marker of systemic nitric oxide (NO) production correlates with prospectively studied disease activity in human systemic lupus erythematosus (SLE) and lupus nephritis patients.
METHODS: Eighty-three SLE patients and 40 control subjects were studied longitudinally. The SLE group included 23 patients with lupus nephritis documented by renal biopsy and 26 with a history of lupus nephritis. During each visit, following a 24-hour low-nitrate diet, traditional markers of disease activity and damage were determined. Serum nitrate plus nitrite (NOx) levels were determined by chemiluminescence detection.
RESULTS: NOx levels were higher in SLE patients than in controls during the first visit. In univariate longitudinal analyses, NOx levels were associated with SLE Disease Activity Index scores. In multivariate analyses, NOx levels were associated with serum levels of C3 and creatinine and the urinary protein:creatinine ratio. Among patients with lupus nephritis, those with proliferative lesions had higher NOx levels, and higher NOx levels were associated with accumulation of renal damage and lack of response to therapy.
CONCLUSION: This is the first study to prospectively demonstrate longitudinal associations between serum NOx levels and markers of SLE and lupus nephritis disease activity. The more pronounced association with proliferative lupus nephritis and with longitudinal response to lupus nephritis therapy provides a rationale for the study of reactive intermediates as biomarkers of disease activity and therapeutic targets in proliferative lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18163495      PMCID: PMC2733831          DOI: 10.1002/art.23153

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  42 in total

1.  Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite.

Authors:  M Zou; C Martin; V Ullrich
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

2.  Inducible nitric oxide synthase induction in Thy 1 glomerulonephritis is complement and reactive oxygen species dependent.

Authors:  K Mosley; S N Waddington; H Ebrahim; T Cook; V Cattell
Journal:  Exp Nephrol       Date:  1999 Jan-Feb

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.

Authors:  Ming-Hui Zou; Chaomei Shi; Richard A Cohen
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis.

Authors:  A Furusu; M Miyazaki; K Abe; S Tsukasaki; K Shioshita; O Sasaki; K Miyazaki; Y Ozono; T Koji; T Harada; H Sakai; S Kohno
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

6.  Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity.

Authors:  R Wigand; J Meyer; R Busse; M Hecker
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

7.  Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus.

Authors:  G Rolla; L Brussino; M T Bertero; P Colagrande; M Converso; C Bucca; S Polizzi; F Caligaris-Cappio
Journal:  J Rheumatol       Date:  1997-06       Impact factor: 4.666

8.  Expression of inducible nitric oxide synthase and apoptosis in human lupus nephritis.

Authors:  J S Wang; H H Tseng; D F Shih; H S Jou; L P Ger
Journal:  Nephron       Date:  1997       Impact factor: 2.847

9.  Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus.

Authors:  H M Belmont; D Levartovsky; A Goel; A Amin; R Giorno; J Rediske; M L Skovron; S B Abramson
Journal:  Arthritis Rheum       Date:  1997-10

10.  Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus.

Authors:  M R Gonzalez-Crespo; J A Navarro; J Arenas; E Martin-Mola; J De La Cruz; J J Gomez-Reino
Journal:  Br J Rheumatol       Date:  1998-09
View more
  26 in total

1.  Neurosonological and cognitive screening for evaluation of systemic sclerosis patients.

Authors:  B R Sakr; R E Rabea; A M Aboulfotooh; N A Kishk
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

Review 2.  Environmental exposures, epigenetic changes and the risk of lupus.

Authors:  E C Somers; B C Richardson
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

3.  Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells.

Authors:  Abigail Peairs; Rujuan Dai; Lu Gan; Samuel Shimp; M Nichole Rylander; Liwu Li; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

Review 4.  Diagnosis and treatment of lupus nephritis flares--an update.

Authors:  Ben Sprangers; Marianne Monahan; Gerald B Appel
Journal:  Nat Rev Nephrol       Date:  2012-11-13       Impact factor: 28.314

5.  Middle cerebral artery resistivity and pulsatility indices in systemic lupus erythematosus: evidence for hyperperfusion.

Authors:  E R Greene; K A Yonan; J M Sharrar; W L Sibbitt; C A Roldan
Journal:  Lupus       Date:  2011-11-29       Impact factor: 2.911

6.  Development of Biomarker Models to Predict Outcomes in Lupus Nephritis.

Authors:  Bethany J Wolf; John C Spainhour; John M Arthur; Michael G Janech; Michelle Petri; Jim C Oates
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

Review 7.  The biology of reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 8.  Global trends, potential mechanisms and early detection of organ damage in SLE.

Authors:  Anselm Mak; David A Isenberg; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2012-12-11       Impact factor: 20.543

Review 9.  Biomarkers for lupus nephritis: a critical appraisal.

Authors:  Chi Chiu Mok
Journal:  J Biomed Biotechnol       Date:  2010-04-19

10.  Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.

Authors:  Peter M Izmirly; Laura Barisoni; Jill P Buyon; Mimi Y Kim; Tania L Rivera; Julie S Schwartzman; Joseph M Weisstuch; David T Liu; Stephen Bernstein; Chung-E Tseng; Howard M Belmont; Charles T Esmon; Joan T Merrill; Anca D Askanase; David B Thomas; Robert M Clancy
Journal:  Rheumatology (Oxford)       Date:  2009-03-13       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.